(Q40637258)

22 September 2017

title

Vaccine strategies to prevent rheumatic fever (English)

1 reference

22 September 2017

Brandt ER

1

1 reference

22 September 2017

Good MF

series ordinal

2

1 reference

22 September 2017

publication date

1 January 1999

1 reference

22 September 2017

1 reference

22 September 2017

volume

19

1 reference

22 September 2017

issue

1

1 reference

22 September 2017

page(s)

89-103

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02786478

22 September 2017

exact match

0 references

cites work

Streptococcal M protein: molecular design and biological behavior.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02786478

Comprehensive review of morbidity and mortality trends for rheumatic fever, streptococcal disease, and scarlet fever: the decline of rheumatic fever

21 January 2018

2 references

Crossref

https://api.crossref.org/works/10.1007%2FBF02786478

21 January 2018

12 December 2020

De novo expression of MHC class I and class II antigens on endomyocardial biopsies from patients with inflammatory heart disease and rejection following heart transplantation

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02786478

Protective immunogenicity and T lymphocyte specificity of a trivalent hybrid peptide containing NH2-terminal sequences of types 5, 6, and 24 M proteins synthesized in tandem

21 January 2018

1 reference

12 December 2020

Protective and nonprotective epitopes of chemically synthesized peptides of the NH2-terminal region of type 6 streptococcal M protein.

1 reference

12 December 2020

Identification of T cell autoepitopes that cross-react with the C-terminal segment of the M protein of group A streptococci

1 reference

12 December 2020

Protective immunity evoked by oral administration of attenuated aroA Salmonella typhimurium expressing cloned streptococcal M protein

1 reference

12 December 2020

Protection against Streptococcal Pharyngeal Colonization with Vaccines Composed of M Protein Conserved Regions

1 reference

12 December 2020

DNA vaccination as an approach to malaria control: current status and strategies

1 reference

12 December 2020

1 reference

12 December 2020

Hyaluronic acid capsule modulates M protein-mediated adherence and acts as a ligand for attachment of group A Streptococcus to CD44 on human keratinocytes

1 reference

12 December 2020

Pneumococcal vaccination in the United States and 20 other developed countries, 1981-1996.

1 reference

12 December 2020

Demonstration of protection in mice from a lethal challenge of three M serotypes of Streptococcus pyogenes using an M-negative vaccine

1 reference

12 December 2020

Circulating T cells of patients with active psoriasis respond to streptococcal M-peptides sharing sequences with human epidermal keratins

1 reference

12 December 2020

Characterization of a conserved helper-T-cell epitope from group A Streptococcal M proteins

1 reference

12 December 2020

Antibody responses to capsular polysaccharide backbone and O-acetate side groups of Streptococcus pneumoniae type 9V in humans and rhesus macaques.

1 reference

12 December 2020

Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci.

1 reference

12 December 2020

Expression of MHC class I and II antigens and the Il-2 receptor in rejection, myocarditis and dilated cardiomyopathy

1 reference

12 December 2020

Molecular analysis of human cardiac myosin-cross-reactive B- and T-cell epitopes of the group A streptococcal M5 protein

1 reference

12 December 2020

Acute rheumatic fever in Auckland, New Zealand: spectrum of associated group A streptococci different from expected.

1 reference

12 December 2020

Mapping a conserved conformational epitope from the M protein of group A streptococci

1 reference

12 December 2020

Antigenic specificity of lymphocytes isolated from valvular specimens of rheumatic fever patients

1 reference

12 December 2020

Recombinant tetravalent group A streptococcal M protein vaccine

1 reference

12 December 2020

Conserved T and B cell epitopes on the M protein of group A streptococci. Induction of bactericidal antibodies.

1 reference

12 December 2020

Streptococcus pneumoniae type 14 polysaccharide-conjugate vaccines: length stabilization of opsonophagocytic conformational polysaccharide epitopes

1 reference

12 December 2020

Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction

1 reference

12 December 2020

Recombinant, octavalent group A streptococcal M protein vaccine

1 reference

12 December 2020

C5a peptidase alters clearance and trafficking of group A streptococci by infected mice

1 reference

12 December 2020

A serological differentiation of human and other groups of hemolytic streptococci

1 reference

12 December 2020

Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci

1 reference

12 December 2020

Intranasal Immunization with Recombinant Group A Streptococcal M Protein Fragment Fused to the B Subunit of Escherichia coli Labile Toxin Protects Mice against Systemic Challenge Infections

1 reference

12 December 2020

Human antibodies to the conserved region of the M protein: opsonization of heterologous strains of group A streptococci

1 reference

12 December 2020

Identification of sequence types among the M-nontypeable group A streptococci

1 reference

12 December 2020

Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A Streptococcus.

1 reference

12 December 2020

Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci

1 reference

12 December 2020

Mapping the minimal murine T cell and B cell epitopes within a peptide vaccine candidate from the conserved region of the M protein of group A streptococcus

1 reference

12 December 2020

Human monoclonal antibodies reactive with antigens of the group A Streptococcus and human heart

1 reference

12 December 2020

1 reference

12 December 2020

WHO programme for the prevention of rheumatic fever/rheumatic heart disease in 16 developing countries: report from Phase I (1986-90). WHO Cardiovascular Diseases Unit and principal investigators

1 reference

12 December 2020

Molecular analysis of polyreactive monoclonal antibodies from rheumatic carditis: human anti-N-acetylglucosamine/anti-myosin antibody V region genes.

1 reference

12 December 2020

Cellular and biochemical responses of human T lymphocytes stimulated with streptococcal M proteins

1 reference

12 December 2020

Tissue distribution of lymphocytes in rheumatic heart valves as defined by monoclonal anti-T cell Antibodies

1 reference

12 December 2020

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

1 reference

12 December 2020

Fibronectin-binding protein I of Streptococcus pyogenes is a promising adjuvant for antigens delivered by mucosal route

1 reference

12 December 2020

The human antibody response to streptococcal C5a peptidase

1 reference

12 December 2020

Localization of immunoglobulin A-binding sites within M or M-like proteins of group A streptococci

1 reference

12 December 2020

Acute rheumatic fever and rheumatic heart disease in the top end of Australia's Northern Territory.

1 reference

12 December 2020

Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci

1 reference

12 December 2020

Vaccination with streptococcal extracellular cysteine protease (interleukin-1β convertase) protects mice against challenge with heterologous group A streptococci

1 reference

12 December 2020

Lipoteichoic acid and M protein: dual adhesins of group A streptococci

1 reference

12 December 2020

Human heart-infiltrating T-cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins

1 reference

12 December 2020

Group A streptococcal M proteins: virulence factors and protective antigens

1 reference

12 December 2020

Human and murine antibodies cross-reactive with streptococcal M protein and myosin recognize the sequence GLN-LYS-SER-LYS-GLN in M protein.

1 reference

12 December 2020

Group A and group B streptococcal vaccine development. A round table presentation

1 reference

12 December 2020

Group A streptococcus-liposome ELISA antibody titers to group A polysaccharide and opsonophagocytic capabilities of the antibodies

1 reference

12 December 2020

Epitopes of streptococcal M proteins that evoke antibodies that cross-react with human brain

1 reference

12 December 2020

Surface-exposed conserved region of the streptococcal M protein induces antibodies cross-reactive with denatured forms of myosin

1 reference

12 December 2020

Intranasal immunization with C5a peptidase prevents nasopharyngeal colonization of mice by the group A Streptococcus

1 reference

12 December 2020

Hyaluronic Acid Synthesis Operon (has) Expression in Group A Streptococci

1 reference

12 December 2020

Clonal differences within M-types of the group A Streptococcus revealed by pulsed field gel electrophoresis

1 reference

12 December 2020

Epitopes of group A streptococcal M protein that evoke cross-protective local immune responses

1 reference

12 December 2020

Passive Protection of Mice against Group A Streptococcal Pharyngeal Infection by Lipoteichoic Acid

1 reference

12 December 2020

M protein mediated adhesion of M type 24 Streptococcus pyogenes stimulates release of interleukin-6 by HEp-2 tissue culture cells

1 reference

12 December 2020

Immunoglobulins to group A streptococcal surface molecules decrease adherence to and invasion of human pharyngeal cells.

1 reference

12 December 2020

Nucleotide sequence of the streptococcal pyrogenic exotoxin type B gene and relationship between the toxin and the streptococcal proteinase precursor.

1 reference

12 December 2020

Conversion of M serotype 24 of Streptococcus pyogenes to M serotypes 5 and 18: effect on resistance to phagocytosis and adhesion to host cells.

1 reference

12 December 2020

Epitopes of streptococcal M proteins shared with cardiac myosin

1 reference

12 December 2020

Streptococcal cysteine protease augments lung injury induced by products of group A streptococci.

1 reference

12 December 2020

Bacterial lipopolysaccharides: candidate vaccines to prevent Neisseria meningitidis and Haemophilus influenzae infections.

1 reference

12 December 2020

Type-specific immunogenicity of a chemically synthesized peptide fragment of type 5 streptococcal M protein.

1 reference

12 December 2020

Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes

1 reference

12 December 2020

The reemergence of serious group A streptococcal infections and acute rheumatic fever.

1 reference

12 December 2020

Functional analysis of IgA antibodies specific for a conserved epitope within the M protein of group A streptococci from Australian Aboriginal endemic communities.

1 reference

12 December 2020

Progress in the development of an HIV-1 vaccine

1 reference

12 December 2020

Complete nucleotide sequence of the streptococcal C5a peptidase gene of Streptococcus pyogenes.

1 reference

12 December 2020

Passive acquired mucosal immunity to group A streptococci by secretory immunoglobulin A

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02786478

1 reference

Dimensions Publication ID

22 September 2017

1022849061

0 references

1 reference